BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 19564794)

  • 1. Nebivolol induces parallel improvement of left ventricular filling pressure and coronary flow reserve in uncomplicated arterial hypertension.
    Galderisi M; D'Errico A; Sidiropulos M; Innelli P; de Divitiis O; de Simone G
    J Hypertens; 2009 Oct; 27(10):2108-15. PubMed ID: 19564794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nebivolol improves coronary flow reserve in hypertensive patients without coronary heart disease.
    Galderisi M; Cicala S; D'Errico A; de Divitiis O; de Simone G
    J Hypertens; 2004 Nov; 22(11):2201-8. PubMed ID: 15480106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy.
    Galderisi M; Cicala S; De Simone L; Caso P; Petrocelli A; Pietropaolo L; Celentano A; Mininni N; de Divitiis O
    Ital Heart J; 2001 Sep; 2(9):677-84. PubMed ID: 11666096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathy.
    Erdogan D; Gullu H; Caliskan M; Ciftci O; Baycan S; Yildirir A; Muderrisoglu H
    Heart; 2007 Mar; 93(3):319-24. PubMed ID: 17065184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent association of coronary flow reserve with left ventricular relaxation and filling pressure in arterial hypertension.
    Galderisi M; de Simone G; D'Errico A; Sidiropulos M; Viceconti R; Chinali M; Mondillo S; de Divitiis O
    Am J Hypertens; 2008 Sep; 21(9):1040-6. PubMed ID: 18600214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of carvedilol on coronary flow reserve in patients with hypertensive left-ventricular hypertrophy.
    Xiaozhen H; Yun Z; Mei Z; Yu S
    Blood Press; 2010 Feb; 19(1):40-7. PubMed ID: 20001392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary flow reserve and myocardial diastolic dysfunction in arterial hypertension.
    Galderisi M; Cicala S; Caso P; De Simone L; D'Errico A; Petrocelli A; de Divitiis O
    Am J Cardiol; 2002 Oct; 90(8):860-4. PubMed ID: 12372574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).
    Müller-Brunotte R; Kahan T; Malmqvist K; Ring M; Edner M
    Am J Hypertens; 2006 Sep; 19(9):927-36. PubMed ID: 16942935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Short-term effect of nebivolol on the left ventricular diastolic function].
    Demiralp E; Kardeşoğlu E; Celik T; Cebeci BS; Ozmen N; Işilak Z; Ulusoy RE; Dinçtürk M
    Anadolu Kardiyol Derg; 2004 Dec; 4(4):323-36. PubMed ID: 15590361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incremental value of pulse wave velocity in the determination of coronary microcirculatory dysfunction in never-treated patients with essential hypertension.
    Ikonomidis I; Lekakis J; Papadopoulos C; Triantafyllidi H; Paraskevaidis I; Georgoula G; Tzortzis S; Revela I; Kremastinos DT
    Am J Hypertens; 2008 Jul; 21(7):806-13. PubMed ID: 18497732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between regression of hypertensive left ventricular hypertrophy and improvement of coronary flow reserve].
    Xu R; Zhang Y; Zhang M; Ge ZM; Li XC; Zhang W
    Zhonghua Yi Xue Za Zhi; 2003 Apr; 83(8):658-61. PubMed ID: 12887823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of nebivolol and atenolol on transmitral diastolic filling parameters in patients with essential hypertension.
    Tuncer M; Guntekin U; Gunes Y; Gumrukcuoglu HA; Eryonucu B
    Adv Ther; 2008 Jun; 25(6):619-26. PubMed ID: 18563311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the beta-blocker nebivolol increase coronary flow reserve?
    Togni M; Vigorito F; Windecker S; Abrecht L; Wenaweser P; Cook S; Billinger M; Meier B; Hess OM
    Cardiovasc Drugs Ther; 2007 Apr; 21(2):99-108. PubMed ID: 17235472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of impaired coronary microcirculation to increased urine albumin excretion in patients with systemic hypertension and no epicardial coronary arterial narrowing.
    Tsiachris D; Tsioufis C; Dimitriadis K; Syrseloudis D; Rousos D; Kasiakogias A; Papademetriou V; Tousoulis D; Stefanadis C
    Am J Cardiol; 2012 Apr; 109(7):1026-30. PubMed ID: 22221953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of valsartan on left ventricular myocardial functions in hypertensive patients with left ventricular hypertrophy.
    Kucukler N; Kurt IH; Topaloglu C; Gurbuz S; Yalcin F
    J Cardiovasc Med (Hagerstown); 2012 Mar; 13(3):181-6. PubMed ID: 22306782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary microvascular function is independently associated with left ventricular filling pressure in patients with type 2 diabetes mellitus.
    Kawata T; Daimon M; Miyazaki S; Ichikawa R; Maruyama M; Chiang SJ; Ito C; Sato F; Watada H; Daida H
    Cardiovasc Diabetol; 2015 Aug; 14():98. PubMed ID: 26242308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of hypertension and hypertension-related left ventricle hypertrophy on right ventricle function.
    Tumuklu MM; Erkorkmaz U; Ocal A
    Echocardiography; 2007 Apr; 24(4):374-84. PubMed ID: 17381646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary flow reserve in hypertensive patients with appropriate or inappropriate left ventricular mass.
    Galderisi M; de Simone G; Cicala S; De Simone L; D'Errico A; Caso P; de Divitiis O
    J Hypertens; 2003 Nov; 21(11):2183-8. PubMed ID: 14597863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of reduction of coronary flow reserve in patients with type 2 diabetes mellitus or arterial hypertension without angiographically determined epicardial coronary stenosis.
    Galderisi M; Capaldo B; Sidiropulos M; D'Errico A; Ferrara L; Turco A; Guarini P; Riccardi G; de Divitiis O
    Am J Hypertens; 2007 Dec; 20(12):1283-90. PubMed ID: 18047918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness.
    Kampus P; Serg M; Kals J; Zagura M; Muda P; Karu K; Zilmer M; Eha J
    Hypertension; 2011 Jun; 57(6):1122-8. PubMed ID: 21536983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.